| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |